Research ArticleMIRD Dose Estimate Report No. 13
Radiation Absorbed Dose from Technetium-99m-Labeled Bone Imaging Agents
David A. Weber, P. Todd Makler, Evelyn E. Watson, Jack L. Coffey, Stephen R. Thomas, Jack London and Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine
Journal of Nuclear Medicine June 1989, 30 (6) 1117-1122;
David A. Weber
P. Todd Makler Jr.
Evelyn E. Watson
Jack L. Coffey
Stephen R. Thomas


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Radiation Absorbed Dose from Technetium-99m-Labeled Bone Imaging Agents
David A. Weber, P. Todd Makler, Evelyn E. Watson, Jack L. Coffey, Stephen R. Thomas, Jack London, Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine
Journal of Nuclear Medicine Jun 1989, 30 (6) 1117-1122;
Radiation Absorbed Dose from Technetium-99m-Labeled Bone Imaging Agents
David A. Weber, P. Todd Makler, Evelyn E. Watson, Jack L. Coffey, Stephen R. Thomas, Jack London, Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine
Journal of Nuclear Medicine Jun 1989, 30 (6) 1117-1122;
Jump to section
Related Articles
- No related articles found.
Cited By...
- 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways
- Reply: Radiation Exposure Should Not Limit Bone Scintigraphy with 18F-NaF
- An Introduction to Na18F Bone Scintigraphy: Basic Principles, Advanced Imaging Concepts, and Case Examples
- Marrow-Sparing Effects of 117mSn(4+)Diethylenetriaminepentaacetic Acid for Radionuclide Therapy of Bone Cancer
- Rhenium-186-labeled Hydroxyethylidene Diphosphonate Dosimetry and Dosing Guidelines for the Palliation of Skeletal Metastases from Androgen-independent Prostate Cancer